Ophthalmic solutions
US11944638B2 · kind B2 · utility
0Cited by
8References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 10, 2022 |
| Grant date | Apr 2, 2024 |
| Priority date | — |
| Expiry date | Mar 10, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L12/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An ophthalmically compatible solution includes (a) about 0.005 to about 2 wt. %, based on the total weight of the ophthalmically compatible solution, of hyaluronic acid or a salt thereof; (b) about 0.01 to about 1 wt. %, based on the total weight of the ophthalmically compatible solution, of erythritol; (c) sodium chloride, potassium chloride or any combination thereof; and (d) one or more buffers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.